Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
5.36 (1y: +215%)
Market Cap 1.55 B P/E(ttm)
Enterprise Value 1.8 B P/B
MNKD- NAS (USA)
MannKind Corporation
Not Rated
Top Ranked Predictable Companies
$5.36
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,550Revenue $M0.0Net Margin (%)-483,903.0Z-Score-15.3
Enterprise Value $M1,819EPS $-0.8Operating Margin %-419,885.7F-Score0
P/E(ttm))0Cash Flow Per Share $-1.1Pre-tax Margin (%)-485,069.0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0.2Cash flow > EarningsN
Price/Sales13,8505-y EBITDA Growth Rate %-35.0Current Ratio0.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-67.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M289ROI % (ttm)-83.8Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
MNKDJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$2.31 - $3.56
($2.75)		 $ 5.3695%Sold Out0
MNKDJean-Marie Eveillard 2012-12-31 Buy 0.01%$1.85 - $2.83
($2.16)		 $ 5.36148%New holding, 800000 sh.800,000
MNKDGeorge Soros 2007-09-30 Sold Out -0.01%$8.87 - $13.09
($10.2)		 $ 5.36-48%Sold Out0
MNKDGeorge Soros 2007-06-30 Buy 0.01%$11.46 - $14.95
($13.3)		 $ 5.36-60%New holding, 13493 sh.13,493
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 4

MNKD is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MNKD Jean-Marie Eveillard 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palumbo DianeVice President, Human Resource 2013-05-16Sell26,829$5.252.1view
PFEFFER MATTHEW JCorporate VP and CFO 2013-05-15Sell10,000$57.2view
PFEFFER MATTHEW JCorporate VP and CFO 2012-12-31Buy1,056$1.95174.87view
MANN ALFRED E10% Owner 2012-12-21Buy40,000,000$2.59106.95view
COHEN ABRAHAM EDirector 2012-08-17Sell2,350$2.29134.06view
PFEFFER MATTHEW JCorporate VP and CFO 2012-06-30Buy1,054$1.95174.87view
MANN ALFRED E10% Owner 2012-06-27Buy31,250,000$2.47117view
Martens JuergenCorporate VP 2012-05-25Buy21,667$1.68219.05view
Martens JuergenCorporate VP 2012-02-27Buy13,745$2.24139.29view
Edstrom HakanPresident & COO 2012-02-27Buy20,000$2.22141.44view

Press Releases about MNKD:

Quarterly/Annual Reports about MNKD:

News about MNKD:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
Weekly Top Insider Buys: HRB, LPI, GCO, GAM, SONC, MNKD Jul 09 2012 
Canadian Guru Francis Chou Buys Bank of America Warrants, Citigroup, Sears, Feb 16 2012 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
The Details of the Afrezza Approval Delay Jan 31 2012 
MannKind’s Afrezza Was to Be Approved; What Happened Next? Jan 30 2012 
Why MannKind merits your attention? Jan 30 2012 
5 Speculative Biotech Stocks to Consider Buying Now Jan 24 2012 
Canadian Value Investor Francis Chou Buys Abitibibowater, Bank Of America Warrants, Wells Fargo Warr Feb 16 2011 
MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 

More From Our Partners
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying May 18 2013 - BENZINGA

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK